Haemonetics | HAE - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Baxter International USD 78M 20M 2026-03
Becton, Dickinson and Co. USD 132M 17M 2026-06
Boston Scientific USD 96M 6M 2026-06
Cerus USD 2.33M 96K 2024-06
Cooper Companies USD 20.9M 1.5M 2026-03
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 83M 4M 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Haemonetics USD 5.08M 2.32M 2026-03
ICU Medical USD 18.53M 2.11M 2026-03
Intuitive Surgical USD 20.88B 765.6M 2026-06
Medtronic USD 186M 10M 2026-06
Merit Medical Systems USD 12.12M 5.59M 2026-06
Neogen USD 13.9M 356K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Plus Therapeutics USD 62K 25K 2023-12
Quidel USD 5.63B 5.58B 2026-03
ResMed USD 8.79M 14.55M 2025-09
STAAR Surgical USD 800K 799K 2025-09
Steris USD 15.8M 700K 2026-06
Stryker USD 47.93B 1.64B 2026-06
Teleflex USD 27.95M 2.24M 2026-06
Terumo JPY 1.48B 51M 2026-06
Thermo Fisher Scientific USD 354M 11M 2026-03
US Physical Therapy USD 3.21M 422K 2026-06
Zimmer Biomet Holdings USD 22.8B 22.73B 2026-06